The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells
Abstract
The vertebrate immune system recognizes bacterial DNA based on the presence of unmethylated CpG-dinucleotides in particular base contexts (“CpG motifs”). In contrast to mice, knowledge about CpG-mediated effects on human B cells is poor. In the present study we identify and determine an optimal human CpG motif. A phosphodiester oligonucleotide containing this motif strongly stimulated CD86, CD40, CD54, and MHC class II expression, IL-6 synthesis, and proliferation of primary human B cells. These effects required internalization of the oligonucleotide and endosomal maturation. The molecular mechanism of action of this CpG motif was associated with the sustained induction of the NF-κB p50/p65 heterodimer and of the transcription-factor complex AP-1. Transcription-factor activation by CpG DNA was preceded by increased phosphorylation of the stress kinases c-Jun N-terminal kinase and p38, and of activating transcription factor-2. In contrast to CpG, signaling through the B cell receptor led to activation of extracellular receptor kinase and to phosphorylation of a different isoform of c-Jun N-terminal kinase. These studies define the structure of a highly active human CpG motif and characterize its molecular mechanism of action in primary human B cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although GTCGTT has been proposed as an optimal human TLR9 activating sequence, other sequences of CpG ODN are also activating and questions remain regarding the potency of activation through sequence context, TLR secondary structure, and cell type [96][97][98].”
From Risk mitigation of immunogenicity: a key to personalized retinal gene therapy (2021) · cites this paper as [96]
Citations
Cites
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Self-citationA MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J. D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,647
The stress-activated protein kinase subfamily of c-Jun kinases
Kyriakis, J. M., Banerjee, P. T., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., & Woodgett, J. R. (1994) · Nature · doi:10.1038/369156a0 · Cited by 2,601
The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases
Karin, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16483 · Cited by 2,423
Determination of lymphocyte division by flow cytometry
Lyons, A. B., & Parish, C. R. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90236-4 · Cited by 1,650
Transcription Factor ATF2 Regulation by the JNK Signal Transduction Pathway
Gupta, S., Campbell, D., Dérijard, B., & Davis, R. J. (1995) · Science · doi:10.1126/science.7824938 · Cited by 1,433
CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity
Chu, R. S., Targoni, O. S., Krieg, A. Μ., Lehmann, P., & Harding, C. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1623 · Cited by 1,001
Self-citationBallas, Z. K., Rasmussen, W. L., & KRIEG, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1840 · Cited by 758
Self-citationDavis, H. L., Weeranta, R., Waldschmidt, T. J., Tygrett, L. T., Schorr, J., & Krieg, A. Μ. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.870 · Cited by 676
Self-citationHäcker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R. M., Sparwasser, T. D., Heeg, K. M., Lipford, G. B., & Wagner, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6230 · Cited by 670
Flagged first, then by citations
Research works printed but not linked: 44
- 1994, Proc. Natl. Acad. Sci. USA, 3799
- 1995, Nature, 546
- 1998, J. Immunol., 5898
- 1998, Trends Microbiol., 23
- 1998, J. Exp. Med., 2335
- 1996, J. Immunol., 2116
- 1997, Clin. Immunol. Immunopathol., 185
- 1998, EMBO J., 6230
- 1998, Eur. J. Immunol., 2045
- 1998, J. Immunol., 3042
- 1996, J. Immunol., 4570
- 1996, J. Immunol., 1840
- 1998, J. Immunol., 4493
- 1996, J. Immunol., 5394
- 1998, J. Immunol., 4755
- 1997, Proc. Natl. Acad. Sci. USA, 10833
- 1998, Vaccine, 1216
- 1998, J. Immunol., 870
- 1998, Proc. Natl. Acad. Sci. USA, 15553
- 1998, J. Immunol., 3627
- 1997, J. Exp. Med., 1623
- 1997, Blood, 2994
- 1998, J. Immunol., 2428
- 1998, J. Immunol., 2555
- 1994, Jpn. J. Cancer Res. (GANN), 775
- 1996, Clin. Immunol. Immunopathol., 115
- 1993, Biochem. Pharmacol., 2037
- 1996, J. Lab. Clin. Med., 329
- 1996, J. Clin. Invest., 1119
- 1996, Mol. Med., 429
- 1999, Gene Ther., 893
- 1999, Proc. Natl. Acad. Sci. USA, 9305
- 1996, Antisense Nucleic Acid Drug Dev., 291
- 1998, J. Pharmacol. Exp. Ther., 920
- 1994, J. Immunol. Methods, 131
- 1998, J. Immunol., 1122
- 1995, J. Biol. Chem., 16483
- 1991, Biochim. Biophys. Acta, 129
- 1995, Science, 389
- 1992, Antisense Res. Dev., 325
- 1994, Mol. Cell. Biol., 5349
- 1994, Nature, 156
- 1994, Science, 808
- 1995, EMBO J., 1785
Cited by
Sorted by citations
Items 401–500 of 605
Chapter 12 Liposome-Mediated Therapy of Neuroblastoma
Paolo, D. D., Loi, M., Pastorino, F., Brignole, C., Marimpietri, D., Becherini, P., Caffa, I., Zorzoli, A., Longhi, R., Gagliani, M. C., et al. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(09)65012-6 · Cited by 14
Lee, Y., Lee, Y. S., Cho, S. Y., & Kwon, H. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.03.004 · Cited by 14
Ohto, U. (2017) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c17-00323 · Cited by 14
Zhang, M., Zhou, F., Zhang, H., Cui, M., Wang, M., & Liu, K. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.106044 · Cited by 14
Zhao, F., Liu, S., Zhang, X., Yu, J., Zeng, T., Gu, W., Cao, X., Chen, X., & Wu, Y. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.23064 · Cited by 13
Technical Improvements in the Computational Target Search for Antisense Oligonucleotides
Far, R. K., Leppert, J., Frank, K., & Sczakiel, G. (2005) · Oligonucleotides · doi:10.1089/oli.2005.15.223 · Cited by 13
Bjersing, J. L., Eriksson, K., Tarkowski, A., & Collins, L. V. (2004) · Inflammation · doi:10.1023/b:ifla.0000014710.44475.94 · Cited by 13
Choi, S.-S., Chung, E., & Jung, Y. (2010) · The Journal of Microbiology · doi:10.1007/s12275-010-0053-6 · Cited by 13
Hirose, I., Tanaka, H., Takahashi, G., Wakahara, K., Tamari, M., Sakamoto, T., Kojima, S., Inagaki, N., & Nagai, H. (2008) · International Archives of Allergy and Immunology · doi:10.1159/000128581 · Cited by 13
Karagiannis, P., Corrêa, I., Chauhan, J., Cheung, A., Dominguez-Rodriguez, D., Terranova-Barberio, M., Harris, R. J. C., Crescioli, S., Spicer, J. F., Bokemeyer, C., et al. (2021) · Clinical & Experimental Immunology · doi:10.1093/cei/uxab005 · Cited by 12
Zheng, X., Hu, N., Liu, J., Zhao, K., Li, H., Wang, J., Zhang, M., Zhang, L., Song, L., Lyu, Y., et al. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05453-z · Cited by 12
Viryasova, G. M., Golenkina, E. A., Galkina, S. I., Gaponova, T. V., Romanova, Y. M., & Sud’ina, G. F. (2016) · Biochimie · doi:10.1016/j.biochi.2016.03.010 · Cited by 12
Angulo, C., Alamillo, E., Hırono, I., Kondo, H., Jirapongpairoj, W., Pérez‐Urbiola, J. C., & Reyes‐Becerril, M. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.03.025 · Cited by 12
All three classes of CpG ODNs up-regulate IP-10 gene in pigs
Dar, A. M., Nichani, A., Lai, K., Potter, A. A., Gerdts, V., Babiuk, L. A., & Mutwiri, G. (2009) · Research in Veterinary Science · doi:10.1016/j.rvsc.2009.10.003 · Cited by 12
Molecular Biology of the Host-Microbe Interaction in Periodontal Diseases
Rossa, C., & Kirkwood, K. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0416-7.00025-1 · Cited by 13
Ali, M. F., Dasari, H., Keulen, V. P. V., Cornec, D., Vasmatzis, G., Peikert, T., & Carmona, E. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-04199-2 · Cited by 12
Ayash‐Rashkovsky, M., Bentwich, Z., & Borkow, G. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.05.012 · Cited by 12
Bacteria-mediated cancer therapy: A versatile bio-sapper with translational potential
Luo, M., Chen, X., Gao, H., Yang, F., Chen, J., & Qiao, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.980111 · Cited by 10
Efficient computation of motif discovery on Intel Many Integrated Core (MIC) Architecture
Peng, S., Cheng, M., Huang, K., Cui, Y., Zhang, Z., Guo, R., Zhang, X., Yang, S., Liao, X., Lu, Y., et al. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2276-1 · Cited by 11
Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas
Su, C., Kim, S. K., Wang, C. X., Kirsch, D. G., & Monjazeb, A. M. (2024) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2024.01.001 · Cited by 11
Jiling, R., Sun, L., Yang, L., Wang, H., Wan, M., Zhang, P., Yu, H., Guo, Y., Yu, Y., & Wang, L. (2010) · Vaccine · doi:10.1016/j.vaccine.2009.12.077 · Cited by 11
Kinetic Analysis of CpG-Induced Mouse B Cell Growth and Ig Production
Kim, Y., Lee, S., Yoo, Y., Lee, J., Park, J., & Park, S. (2012) · Immune Network · doi:10.4110/in.2012.12.3.89 · Cited by 11
Kapp, K., Schneider, J., Schneider, L., Gollinge, N., Jänsch, S., Schroff, M., Wittig, B., & Kleuss, C. (2016) · Immunity Inflammation and Disease · doi:10.1002/iid3.126 · Cited by 11
Adjuvant Allergen Fusion Proteins as Novel Tools for the Treatment of Type I Allergies
Blanco‐Pérez, F., Papp, G., Goretzki, A., Möller, T.-M., Anzaghe, M., & Schülke, S. (2019) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-019-00551-8 · Cited by 11
Dampmann, M., Görgens, A., Möllmann, M., Murke, F., Duhrsen, U., Giebel, B., & Dürig, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228674 · Cited by 10
Gadhoumi, H., Gullo, M., Vero, L. D., Martinez-Rojas, E., Tounsi, M. S., & Hayouni, E. A. (2021) · Applied Sciences · doi:10.3390/app11136089 · Cited by 13
Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies
Smith, S. A., & Crowe, J. E. (2015) · ASM Press eBooks · doi:10.1128/9781555817411.ch8 · Cited by 12
CpG ODN As a Th1 Immune Enhancer for Prophylactic and Therapeutic Vaccines
Krieg, A. Μ., & Davis, H. L. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-970-7_6 · Cited by 11
Self-citationMatsumoto, S., Yamashita, M., Katakura, Y., Noguchi, E., Aiba, Y., Ichikawa, A., Teruya, K., & Shirahata, S. (2006) · Cytotechnology · doi:10.1007/s10616-006-9003-x · Cited by 11
Hu, D., Su, X., Sun, R., Yang, G., Wang, H., Jiling, R., Sun, L., Wu, X., Hu, X., Yu, Y., et al. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2008.12.008 · Cited by 11
Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines
Ongkudon, C. M., Ho, J., & Danquah, M. K. (2010) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2010.483460 · Cited by 11
Rodriguez, J. M., Elı́as, F., Fló, J., López, R. A., Zorzópulos, J., & Montaner, A. D. (2006) · Oligonucleotides · doi:10.1089/oli.2006.16.275 · Cited by 11
Hegele, A., Dalpke, A. H., Barth, P. J., Varga, Z., Heeg, K. M., Hofmann, R. W., & Olbert, P. J. (2004) · PubMed · Cited by 11
DNA-based immunotherapy to treat atopic disease
Tsalik, E. L. (2005) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61163-5 · Cited by 11
Structural requirements and applications of inhibitory oligodeoxyribonucleotides
Ashman, R. F., & Lenert, P. S. (2007) · Immunologic Research · doi:10.1007/s12026-007-0065-4 · Cited by 11
SHEN, K., Högstrand, C., & DAVIES, D. (2005) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2005.05.002 · Cited by 11
Manzotti, C. N., Tipping, H., Perry, L., Mead, K. I., Blair, P. J., Zheng, Y., & Sansom, D. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(2002010)32:10 · Cited by 142
Toll-like receptor interference in myeloid dendritic cells through head and neck cancer.
Frenzel, H., Hoffmann, B., Brocks, C., Schlenke, P., Pries, R., & Wollenberg, B. (2006) · PubMed · Cited by 11
Characterization of cooperative PS-oligo activation of human TLR9
Pollak, A. J., Zhao, L., & Crooke, S. T. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.08.011 · Cited by 10
Górny, M. K. (2012) · Antibody Technology Journal · doi:10.2147/anti.s30489 · Cited by 10
Watanabe, T. (2021) · Cancers · doi:10.3390/cancers14010141 · Cited by 11
Rodriguez, J. M., Elı́as, F., Montaner, A. D., Fló, J., López, R. A., Zorzópulos, J., Franco, R., Lenial, S. P., Salon, M. L., Pirpignani, M. L., et al. (2006) · PubMed · Cited by 10
Wang, L., Jiang, W., Ding, G., Cao, H., Lu, Y., Luo, P., Zhou, H., & Zheng, J. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.01.005 · Cited by 10
Carbonari, M., Mancaniello, D., Tedesco, T., & Fiorilli, M. (2008) · Cytometry Part A · doi:10.1002/cyto.a.20521 · Cited by 10
Kang, Y. J., Kim, D. S., & Kim, K. H. (2012) · Aquaculture Research · doi:10.1111/are.12020 · Cited by 10
Robert-Tissot, C., Rüegger, V. L., Cattori, V., Meli, M. L., Riond, B., Moore, P. F., Engels, M., Franchini, M., Hofmann‐Lehmann, R., & Lutz, H. (2012) · Veterinary Research · doi:10.1186/1297-9716-43-60 · Cited by 10
Functional alteration of myeloid dendritic cells through head and neck cancer.
Brocks, C., Pries, R., Frenzel, H., Ernst, M., Schlenke, P., & Wollenberg, B. (2007) · PubMed · Cited by 10
Вейко, Н. Н., Kalashnikova, E. A., Kokarovtseva, S. N., Kostyuk, S. V., Ermakov, A. V., Ivanova, S. M., Riazantseva, T. A., Egolina, N. A., Lyapunova, N. A., & Dm, S. (2006) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-006-0384-9 · Cited by 10
Aggarwal, P., Pandey, R., & Seth, P. (2005) · Viral Immunology · doi:10.1089/vim.2005.18.213 · Cited by 10
Liang, H., Reich, C. F., Pisetsky, D. S., & Lipsky, P. E. (2001) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2001.01004.x · Cited by 10
BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists
Bai, L., Zhou, L., Han, W., Chen, J., Gu, X., Hu, Z., Yang, Y., Li, W., Zhang, X., Niu, C. S., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03969-z · Cited by 9
Qi, C., Sun, J., Li, Y., Gu, M., Goulette, T., You, X., Sela, D. A., Wang, X., & Xiao, H. (2018) · Food & Function · doi:10.1039/c8fo00109j · Cited by 9
Montesoro, E., Castelli, G., Morsilli, O., Nisini, R., Stafsnes, M., Carè, A., Peschle, C., & Chelucci, C. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401748 · Cited by 9
Liu, L. G., Chang, C. R., Dai, J., Nikitin, P. A., Jima, D. D., Davé, S. S., & Luftig, M. A. (2017) · mSphere · doi:10.1128/msphere.00305-17 · Cited by 9
Uzonyi, B., Mácsik‐Valent, B., Lukácsi, S., Kiss, R., Török, K., Kremlitzka, M., Bajtay, Z., Demeter, J., Bödör, C., & Erdei, A. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.05.016 · Cited by 9
Guo, Y., Wu, D., Wang, K. ‐., & Sun, S. (2007) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2007.02013.x · Cited by 9
Kunisawa, J., McGhee, J. R., & Kiyono, H. (2007) · Springer eBooks · doi:10.1007/978-0-387-72232-0_14 · Cited by 9
Hoogendoorn, M., Wolbers, J. O., Smit, W. M., Schaafsma, M. R., Jedema, I., Barge, R. M. Y., Willemze, R., & Falkenburg, J. H. F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2425 · Cited by 9
pUC18-CpG Is an Effective Adjuvant for a Duck Tembusu Virus Inactivated Vaccine
Ren, X., Wang, X., Zhang, S., Gao, X., Fang, L., Wang, X., Lin, W., Jia, H., Guo, X., Xin, T., et al. (2020) · Viruses · doi:10.3390/v12020238 · Cited by 8
Kang, Y. J., & Kim, K. H. (2014) · Aquaculture · doi:10.1016/j.aquaculture.2014.03.035 · Cited by 8
Chu, C.-Y., Lee, S.-C., Liu, S.-S., Lin, Y.-M., Shen, P., Yu, C. L., Lee, K., Zhao, X., & Lee, J. (2011) · Nucleic Acid Therapeutics · doi:10.1089/nat.2010.0275 · Cited by 8
How to Deal with Polarized Th2 Cells: Exploring the Achilles’ Heel
Smits, H. H., Hilkens, C. M. U., Kaliński, P., Kapsenberg, M. L., & Wierenga, E. A. (2001) · International Archives of Allergy and Immunology · doi:10.1159/000049500 · Cited by 8
Hanagata, N., Li, X., Chen, M., Li, J., & Hattori, S. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s152141 · Cited by 8
Crooke, S. T. (2003) · Wiley eBooks · doi:10.1002/0471266949.bmc024 · Cited by 8
Ren, H., Li, H., Cao, L., Wang, Z., Zhou, Y., Guo, J., Zhang, Y., Liu, H., & Xu, W. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.09.071 · Cited by 7
Single-stranded oligodeoxynucleotides induce plant defence in Arabidopsis thaliana
Toum, L., Conti, G., Guerriero, F. C., Conforte, V. P., Garolla, F. A., Asurmendi, S., Vojnov, A. A., & Gudesblat, G. E. (2020) · Annals of Botany · doi:10.1093/aob/mcaa061 · Cited by 7
Du, H., Xia, S., Hai-feng, S. O. N. G., Li, N., Shang, M.-M., Jia, Z. O. U., Wang, Q., Ou, L., Xiao, S. U. N., Ji, A., et al. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00628.x · Cited by 7
Immunological effects of different types of synthetic CpG oligodeoxynucleotides on porcine cells
Li, R., Zhang, L., Shi, P., Deng, H., Li, Y. L., Ren, J., Fu, X., Zhang, L., & Huang, J. (2017) · RSC Advances · doi:10.1039/c7ra04493c · Cited by 7
Byadgi, O. V., Uyen, N. H. N., Chou, R.-L., Guo, J., Lee, Y., Lee, J., & Cheng, T. (2018) · Aquaculture · doi:10.1016/j.aquaculture.2018.04.035 · Cited by 7
Chen, W., Langer, R. M., Janczewska, S., Furian, L., Geary, R. S., Qu, X., Wang, M., Verani, R. R., Condon, T., Stecker, K., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000149505.53886.27 · Cited by 7
Khorramizadeh, M. R., Hosseinzadeh, S., Safavifar, F., Saadat, F., Aalizadeh, N., Falak, R., Jadali, Z., & Pezeshki, M. Z. (2007) · PubMed · Cited by 7
Characterization of the TLR9-Activating Potential of LNA-Modified Antisense Oligonucleotides
Riera-Tur, I., Hinterdobler, J., Maaske, A., Sadewasser, A., Schell, M., Sekar, J., Michel, S., Klar, R., & Jaschinski, F. (2024) · Nucleic Acid Therapeutics · doi:10.1089/nat.2024.0013 · Cited by 5
Ashman, R. F., Goeken, J. A., & Lenert, P. S. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.02.023 · Cited by 6
Isolation of human myeloid dendritic cells from tumor tissue and peripheral blood.
Brocks, C., Graefe, H., Frenzel, H., Pries, R., & Wollenberg, B. (2006) · PubMed · Cited by 6
Li, X., Xu, G., Qiao, T., Yuan, S., Zhuang, X., Zhang, J., & Sun, H. B. (2016) · Journal of Inflammation · doi:10.1186/s12950-016-0125-4 · Cited by 6
Tarhini, A. A., Kirkwood, J. M., & Krieg, A. Μ. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440902824784 · Cited by 6
Self-citationBinding and Uptake of Immunostimulatory CpG Oligodeoxynucleotides by Human Neuroblastoma Cells
Guo, L., & Schluesener, H. J. (2004) · Oligonucleotides · doi:10.1089/oli.2004.14.287 · Cited by 6
Fleige, L., & Capellino, S. (2024) · Cells · doi:10.3390/cells13221822 · Cited by 5
Mende, M., Hopert, A., Wünsche, W., Overhoff, M. G., Detzer, A., Börngen, K., Schlenke, P., Kirchner, H., & Sczakiel, G. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02497.x · Cited by 5
Toll-like receptors targeting technology for the treatment of lymphoma
Batool, M., Anwar, M. A., & Choi, S.-D. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1233964 · Cited by 7
Liposomal encapsulation enhances the activity of immunostimulatory oligonucleotides
Tam, Y. K. (2006) · Future Lipidology · doi:10.2217/17460875.1.1.35 · Cited by 5
Inhibitory effects of 2,6-di-O-methyl-α-cyclodextrin on Poly I:C signaling in macrophages
Motoyama, K., Hashimoto, Y., Hirayama, F., Uekama, K., & Arima, H. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.10.003 · Cited by 5
Itou, T., Endo, T., Sakai, T., Karlsson, A., & Collins, L. V. (2004) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2004.12.003 · Cited by 5
CpG ODN Enhances the Efficacy of Rituximab in Non‐Hodgkin Lymphoma
Buhé, V., Guerrier, T., Youinou, P., Berthou, C., & Loisel, S. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04615.x · Cited by 5
In Vitro Assay of Immunostimulatory Activities of Plasmid Vectors
Jiang, W., Reich, C. F., & Pisetsky, D. S. (2006) · Humana Press eBooks · doi:10.1385/1-59745-168-1:55 · Cited by 5
Animal Vaccine Technology: An Overview
Cheng, L.-T., Chung, Y.-C., Yang, C., Chuang, K., Ke, G., & Chu, C.-Y. (2015) · Toxinology · doi:10.1007/978-94-007-5869-8_37 · Cited by 4
A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivo
Li, Y., Chien, S., Huang, R., Herrmann, A., Zhao, Q., Li, P.-C., Zhang, C., Martincuks, A., Santiago, N. L., Zong, K., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.07.025 · Cited by 7
Li, C., Huang, X., Cai, J., Lu, A., Hao, S., Zhang, Z., Sun, H., & Feng, X. (2022) · Vaccines · doi:10.3390/vaccines10040616 · Cited by 4
Defective TLR9-driven STAT3 activation in B cells of patients with CVID
Borzutzky, A., Rauter, I., Fried, A. J., Rachid, R. A., McDonald, D. R., Hammarström, L. L. G., Grimbacher, B., Abraham, R. S., & Geha, R. S. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.08.008 · Cited by 4
TRADITIONAL BIOCHEMICAL ASSAYS FOR STUDYING TOLL-LIKE RECEPTOR 9
Leifer, C. A., Rose, W., & Botelho, F. M. (2013) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2012.666222 · Cited by 4
Wang, J., Zheng, L., Song, S., Zhang, X., Li, L., Wang, F., Liu, Y. F., & Sun, S. (2007) · Viral Immunology · doi:10.1089/vim.2007.0018 · Cited by 4
Zhang, Y. (2010) · Oncology Reports · doi:10.3892/or.2010.1093 · Cited by 4
Unmethylated CpG oligodeoxynucleotides activate head kidney leukocytes of Atlantic cod, Gadus morhua
Caipang, C. M. A., Gallage, S., Lazado, C. C., Brinchmann, M. F., & Kiron, V. (2010) · Fish Physiology and Biochemistry · doi:10.1007/s10695-010-9393-8 · Cited by 4
Bianchi, S., Allo, V. C. M., Massimino, M., Lavignolle, R., Borzone, F. R., Gomez-Bustillo, S., Chasseing, N. A., Libertun, C., Montaner, A. D., Rabinovich, G. A., et al. (2020) · Nucleic Acid Therapeutics · doi:10.1089/nat.2020.0901 · Cited by 4
Structure–activity relationship of a guanine-free oligodeoxynucleotide as immunopotent inhibitor
Zhang, Y., Wu, X., Wang, Y., Sun, R., Yu, Y., & Wang, L. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.05.014 · Cited by 3
Gürsel, M., Klinman, D. M., & Gürsel, İ. (2013) · Mediators of Inflammation · doi:10.1155/2013/312590 · Cited by 3
Yılmaz, M., Kuru, R. D., Özünal, I. E., Soysal, T., Hacıhanefioğlu, S., & Baykara, O. (2022) · African Health Sciences · doi:10.4314/ahs.v22i3.20 · Cited by 3
Delivery of therapeutic oligonucleotides targeting Dectin-1 using quantized complexes
Sumiya, K., Izumi, H., Matsunaga, T., Tanaka, M., & Sakurai, K. (2022) · Polymer Journal · doi:10.1038/s41428-021-00595-8 · Cited by 3
Seo, J. M., Lee, J., Ji, G. E., & You, J. C. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.9.058 · Cited by 3
CpG Oligodeoxynucleotides for Mucosal Vaccines
Krieg, A. Μ. (2005) · Elsevier eBooks · doi:10.1016/b978-012491543-5/50057-7 · Cited by 3
Self-citation
Metadata
- Authors
- Hartmann, G., & Krieg, A. M.
- Affiliations
- University of Iowa (US)
- Department of Internal Medicine, University of Iowa , Iowa City, IA 52242
- ORCID
- Hartmann, Gunther
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-01
- Volume
- 164
- Issue
- 2
- Pages
- 944-953
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1956007715
- Cited by
- 605
- References
- 48
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 10 · 2023: 6 · 2022: 11 · 2021: 14 · 2020: 11 · 2019: 7 · 2018: 12 · 2017: 21 · 2016: 16 · 2015: 18 · 2014: 16 · 2013: 22 · 2012: 24
- FWCI
- 14.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P01-CA66570, P01CA066570)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-25295, P30DK025295)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- B cell activation, endosomal maturation, AP-1, c-Jun N-terminal kinase, p38 MAPK, ATF2, B cell receptor signaling, interleukin-6, MHC class II expression, CD40, CD86, ICAM-1
- MeSH terms
- B-Lymphocytes, Base Sequence, Binding Sites, DNA, HLA-D Antigens, Humans, Hydrogen-Ion Concentration, Lymphocyte Activation, Oligodeoxyribonucleotides, Phosphorylation, Endosomes, Thionucleotides, Transcription Factors, Interleukin-6, NF-kappa B, Cyclic AMP Response Element-Binding Protein, Intercellular Adhesion Molecule-1, Transcription Factor AP-1, CpG Islands, CD40 Antigens, Mitogen-Activated Protein Kinases, JNK Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, Activating Transcription Factor 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review